NCT05674721View on ClinicalTrials.gov

A Bioequivalence Study of Advil PM Liqui-Gels Minis (Ibuprofen/Diphenhydramine Hydrochloride 200 mg/25 mg) Compared to the Current Marketed Advil PM Liqui-Gels (Ibuprofen/Diphenhydramine Hydrochloride 200 mg/25 mg) in Healthy Adult Subjects Under Fasted Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

January 5, 2023

Primary Completion Date

March 21, 2023

Study Completion Date

March 21, 2023

Conditions
Pain
Interventions
DRUG

Advil PM Liqui-Gels Minis

Ibuprofen/diphenhydramine hydrochloride 200 mg/25 mg, Oral capsule which is a size reduction of the currently marketed reference product.

DRUG

Advil PM Liqui-Gels

Ibuprofen/diphenhydramine hydrochloride 200 mg/25 mg, Oral capsule.

Trial Locations (1)

33144

Syneos Health, Miami

All Listed Sponsors
lead

HALEON

INDUSTRY